1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors.
Saved in:
| Title: | 1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors. |
|---|---|
| Authors: | Coward, J1 (AUTHOR), Lemech, C2 (AUTHOR), Meniawy, T3 (AUTHOR), Dupont, C D4 (AUTHOR), Gonzalez, A M5 (AUTHOR), Lim, M6 (AUTHOR), Savitsky, D4 (AUTHOR), Carini, M7 (AUTHOR), Hu, S8 (AUTHOR), Shebanova, O9 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 133286782 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Coward%2C+J%22">Coward, J</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lemech%2C+C%22">Lemech, C</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meniawy%2C+T%22">Meniawy, T</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dupont%2C+C+D%22">Dupont, C D</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gonzalez%2C+A+M%22">Gonzalez, A M</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lim%2C+M%22">Lim, M</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Savitsky%2C+D%22">Savitsky, D</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carini%2C+M%22">Carini, M</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+S%22">Hu, S</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shebanova%2C+O%22">Shebanova, O</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133286782 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdy288.041 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: 1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Coward, J – PersonEntity: Name: NameFull: Lemech, C – PersonEntity: Name: NameFull: Meniawy, T – PersonEntity: Name: NameFull: Dupont, C D – PersonEntity: Name: NameFull: Gonzalez, A M – PersonEntity: Name: NameFull: Lim, M – PersonEntity: Name: NameFull: Savitsky, D – PersonEntity: Name: NameFull: Carini, M – PersonEntity: Name: NameFull: Hu, S – PersonEntity: Name: NameFull: Shebanova, O IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 10 Text: 2018 Supplement Type: published Y: 2018 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 29 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
